Results 31 to 40 of about 1,308,137 (220)

Soap Bubbles in Outer Space: Interaction of a Domain Wall with a Black Hole [PDF]

open access: yes, 1998
We discuss the generalized Plateau problem in the 3+1 dimensional Schwarzschild background. This represents the physical situation, which could for instance have appeared in the early universe, where a cosmic membrane (thin domain wall) is located near a
A. L. Larsen   +20 more
core   +3 more sources

The Bi-Compact-Open Topology on C(X)

open access: yes, 2016
For the set C(X) of real-valued continuous functions on a Tychonoff space X, the compact-open topology on C(X) is a "set-open topology". This paper studies the separation and countability properties of the space C(X) having the topology given by the join
Jindal, Anubha, Kundu, S., McCoy, R. A.
core   +1 more source

Error-Correcting Codes on Projective Bundles over Deligne–Lusztig Varieties

open access: yesMathematics, 2023
The aim of this article is to give lower bounds on the parameters of algebraic geometric error-correcting codes constructed from projective bundles over Deligne–Lusztig surfaces.
Daniel Camazón Portela   +1 more
doaj   +1 more source

Real‐time assay of ribonucleotide reductase activity with a fluorescent RNA aptamer

open access: yesFEBS Letters, EarlyView.
Ribonucleotide reductases (RNR) synthesize DNA building blocks de novo, making them crucial in DNA replication and drug targeting. FLARE introduces the first single‐tube real‐time coupled RNR assay, which enables isothermal tracking of RNR activity at nanomolar enzyme levels and allows the reconstruction of allosteric regulatory patterns and rapid ...
Jacopo De Capitani   +4 more
wiley   +1 more source

Function‐driven design of a surrogate interleukin‐2 receptor ligand

open access: yesFEBS Letters, EarlyView.
Interleukin (IL)‐2 signaling can be achieved and precisely fine‐tuned through the affinity, distance, and orientation of the heterodimeric receptors with their ligands. We designed a biased IL‐2 surrogate ligand that selectively promotes effector T and natural killer cell activation and differentiation. Interleukin (IL) receptors play a pivotal role in
Ziwei Tang   +9 more
wiley   +1 more source

Conserved structural motifs in PAS, LOV, and CRY proteins regulate circadian rhythms and are therapeutic targets

open access: yesFEBS Letters, EarlyView.
Cryptochrome and PAS/LOV proteins play intricate roles in circadian clocks where they act as both sensors and mediators of protein–protein interactions. Their ubiquitous presence in signaling networks has positioned them as targets for small‐molecule therapeutics. This review provides a structural introduction to these protein families.
Eric D. Brinckman   +2 more
wiley   +1 more source

DEGENERATE DISTRIBUTED CONTROL SYSTEMS WITH FRACTIONAL TIME DERIVATIVE

open access: yesUral Mathematical Journal, 2016
The existence of a unique strong solution for the Cauchy problem to semilinear nondegenerate fractional differential equation and for the generalized Showalter–Sidorov problem to semilinear fractional differential equation with degenerate operator at the
Marina V. Plekhanova
doaj   +1 more source

Dual-topology insertion of a dual-topology membrane protein. [PDF]

open access: yes, 2015
Some membrane transporters are dual-topology dimers in which the subunits have inverted transmembrane topology. How a cell manages to generate equal populations of two opposite topologies from the same polypeptide chain remains unclear.
Bowie, James U   +2 more
core  

Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer

open access: yesMolecular Oncology, EarlyView.
A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath   +13 more
wiley   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy